Rapport Therapeutics (RAPP) Assets Average (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Assets Average data on file, last reported at $505.0 million in Q1 2026.

• On a quarterly basis, Assets Average rose 63.7% year-over-year to $505.0 million in Q1 2026; TTM through Mar 2026 was $505.0 million, a 63.7% increase from a year earlier, with the FY2025 full-year figure at $413.7 million, up 75.9% from the prior year.
• Assets Average for Q1 2026 stood at $505.0 million, down from $523.9 million in the prior quarter.
• Over the last five years, Assets Average for RAPP reached as high as $523.9 million in Q4 2025 and fell as low as $293.8 million in Q2 2025.
• Historically, Assets Average has averaged $386.2 million across 3 years, with a median of $338.6 million in 2024.
• Across the five-year window, Assets Average rose 21.2% in 2025 and soared 63.7% in 2026, its largest moves.
• Year by year, Assets Average stood at $323.0 million in 2024, then soared by 62.17% to $523.9 million in 2025, then decreased by 3.6% to $505.0 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $505.0 million in Q1 2026, $523.9 million in Q4 2025, and $410.4 million in Q3 2025.